Nearly 3 million people have caught the flu. Here’s where the virus is hitting hardest

U.S. influenza activity jumped after Thanksgiving with an 8% week-over-week increase; the CDC estimates about 2.9 million illnesses and roughly 1,200 deaths so far this season, and lists Colorado, New Jersey, New York and Louisiana at “high” transmission while New York City is at “very high” and multiple other states are at “moderate.” The surge is being driven by an H3N2 subclade K strain—historically associated with higher hospitalization and mortality—which raises the prospect of greater healthcare demand and potential workforce and consumer disruptions as flu activity typically peaks between January and March. The CDC has distributed 127 million vaccine doses and recommends vaccination for everyone six months and older who has not yet been immunized.

Analysis

CDC data show an 8% week-over-week rise in positive influenza tests with an estimated 2.9 million illnesses and about 1,200 deaths so far this season. Colorado, New Jersey, New York and Louisiana are classified as "high" transmission and New York City is at "very high," while Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico are in the "moderate" tier.

The surge is being driven by H3N2 subclade K, and the article notes H3N2 strains have historically caused higher hospitalization and mortality, implying elevated near-term healthcare utilization and severity versus typical seasons. The CDC has distributed 127 million vaccine doses and continues to recommend vaccination for everyone six months and older, indicating continued prevention demand despite existing distribution.

U.S. flu activity typically accelerates in December and peaks between January and March, so case counts and hospital pressure are likely to rise before improving. The supplied signals show a moderately negative sentiment score (-0.45) and a modest market-impact score (0.15), suggesting meaningful public-health risk with limited immediate macro market disruption; investors should therefore prioritize regional healthcare capacity, vaccine uptake and operational disruption indicators as leading signals.

Key Decisions for Investors

• Increase short-term exposure to healthcare segments such as hospital operators, vaccine manufacturers and diagnostics providers that are likely to see higher demand from an H3N2-driven season,
• Monitor CDC weekly metrics (positivity rates and state activity tiers) and regional hospitalization data and use worsening trends in high/very-high jurisdictions (e.g., NYC, CO, NJ, LA) as triggers to trim consumer-discretionary and travel exposure in those regions,
• Implement tactical hedges or increase near-term liquidity to manage potential workforce and supply-chain disruptions during the expected January–March peak and watch vaccine uptake relative to the 127 million doses distributed as a signal for demand normalization